Robert Iannone insider trades

Open-market stock purchases and sales by Robert Iannone, EVP, Global Head of R&D & CMO at Jazz Pharmaceuticals plc, from SEC Form 4 filings since Sep 14, 2018.

Recent trades

DateStockTradeValue
Aug 27, 2026JAZZ Jazz Pharmaceuticals plcSold$4.5M
Aug 27, 2026JAZZ Jazz Pharmaceuticals plcSold$2.8M
Aug 27, 2026JAZZ Jazz Pharmaceuticals plcSold$4.5M
Aug 27, 2026JAZZ Jazz Pharmaceuticals plcSold$4.9M
Aug 27, 2026JAZZ Jazz Pharmaceuticals plcSold$2.3M
Aug 27, 2026JAZZ Jazz Pharmaceuticals plcSold$75.8K
Aug 27, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Aug 27, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Aug 27, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Aug 27, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Jul 9, 2026PLRX Pliant Therapeutics, IncBought (not open market)—
Jun 29, 2026AUTL Autolus Therapeutics plcBought (not open market)—
Jun 29, 2026AUTL Autolus Therapeutics plcBought (not open market)—
Mar 5, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$1.2M
Feb 26, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Jan 16, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Jan 16, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$709K
Nov 17, 2025JAZZ Jazz Pharmaceuticals plcSold$1.2M

Companies traded

  • JAZZ Jazz Pharmaceuticals plc: 11 sales, last Aug 27, 2026
  • PLRX Pliant Therapeutics, Inc: other filings, last Jul 9, 2026
  • AUTL Autolus Therapeutics plc: other filings, last Jun 29, 2026
  • ITOS iTeos Therapeutics, Inc: other filings, last Jun 11, 2024
  • JNCE Jounce Therapeutics, Inc: other filings, last May 3, 2023
  • IMMU Immunomedics Inc: other filings, last Sep 14, 2018

Get free alerts when Robert Iannone files a new trade →